Newsletters

Nanomedicine News

Ultrasound Ablation Therapy Pops Bexarotene Prodrug Nanobubbles Within Tumors

Ultrasound Ablation Therapy Pops Bexarotene Prodrug Nanobubbles Within Tumors

In an interdisciplinary collaboration between prominent academic and industry investigators, researchers have discovered a novel method for repositioning an FDA-approved anti-cancer compound so it can specifically target liver cancer tumors. A “triple attack” technique combining chemotherapy, thermal ablation, and hyperthermia provided a highly targeted, yet minimally invasive approach.

Liquid-Metal 'Nano-Terminators' Developed for Cancer Treatment

Liquid-Metal 'Nano-Terminators' Developed for Cancer Treatment

A novel cancer treatment has been developed that uses nanodroplets to deliver drugs to cancerous cells have been developed. The nanodroplets specifically target cancers and once delivered to the cells they release anti-cancer drugs. The new technique has been shown to enhance the effectiveness of anti-cancer drugs.

University of Liverpool to License Patented Solid Drug Nanoparticle Technology to Medicines Patent Pool

University of Liverpool to License Patented Solid Drug Nanoparticle Technology to Medicines Patent Pool

Alongside global events for World Aids Day, the University of Liverpool and the Medicines Patent Pool (MPP), a United Nations-backed public health organisation, have announced a collaboration and licensing agreement to reformulate certain poorly soluble HIV drugs into lower dose formulations for low and middle income countries.

Injectable Nanotube Sensing Technology Could Continuously Analyze Blood Glucose

Injectable Nanotube Sensing Technology Could Continuously Analyze Blood Glucose

What if a diabetic never had to prick a finger to monitor his or her blood-glucose levels, and instead could rely on an internal, nanoscale device to analyze blood continuously and transmit readings to a hand-held scanner?

Researchers Develop New Nanocarriers for Brain Cancer Treatment

Researchers Develop New Nanocarriers for Brain Cancer Treatment

Ting Xu, a polymer researcher from the Materials Sciences Division of Lawrence Berkeley National Laboratory (Berkeley Lab), has developed a novel set of nanocarriers that are produced from the self-assembly of polymers and amphiphilic peptides. Amphiphiles are a type of chemical compounds that have both lipophilic and hydrophilic characteristics. Micelles are spherical amphiphile aggregates. These nanocarriers have a structure of coiled-coil 3-helix micelles and hence, referred to as 3HM.

Precision Medicine Technique that Predicts the Efficacy of Nanomedicines against Different types of Cancer Developed

Precision Medicine Technique that Predicts the Efficacy of Nanomedicines against Different types of Cancer Developed

Researchers at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) have collaborated to develop a new magnetic resonance imaging (MRI) technique to identify which nanotherapeutics are the most useful for treating tumors in different patients. This technique has received the approval of the FDA.

Ultrasensitive Nanotechnology Based Sensor can Detect Early-Stage Cancer

Ultrasensitive Nanotechnology Based Sensor can Detect Early-Stage Cancer

Gold nanoprisms have been used to develop a sensor that can be used to diagnose pancreatic cancer. The gold nanoprisms interact with microRNA in the patients blood to indicate if the disease is present. This novel technology is both cheap and effective.

Unique Fluorescent Nanotags Could Enhance Cellular Detection and Analysis

Unique Fluorescent Nanotags Could Enhance Cellular Detection and Analysis

Inspired by the unique design of a household gadget, a team of scientists have developed bottle-brush nanotags, which can accommodate countless number of fluorophores to facilitate improved cellular identification and analysis. The study has been published in ACS Central Science.

Injectable Clot-Busting Nanotherapeutic and Intra-Arterial Device Combination Shows Promise for Stroke Treatment

Injectable Clot-Busting Nanotherapeutic and Intra-Arterial Device Combination Shows Promise for Stroke Treatment

A new drug-device combination has been developed by the scientists at the New England Center for Stroke Research at UMass Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University for the treatment of potentially fatal blood clots in stroke patients.

Silver Nanoparticle-Integrated Plasma Polymer Coating Prevents Bacterial Infection in Dental Implants

Silver Nanoparticle-Integrated Plasma Polymer Coating Prevents Bacterial Infection in Dental Implants

A unique plasma implant coating, DentaPlas, has been developed that uses silver nanoparticles to prevent infection of dental implants. The dentaplas technology is as robust as conventional implacts yet has a greater lifetime.